companydata.dkPROXEON BIOSYSTEMS ApS: Financial statements 2024
CVR: 26848024
PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 3,703,000 compared with DKK -7,432,000 the year before. Equity amounted to DKK 383,640,000. The solvency ratio was 97.2%.
- Gross Profit
- 0 kr.
- Profit/Loss
- 3,703,000 kr.
- Equity
- 383,640,000 kr.
- Total Assets
- 394,523,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | 3.7 mio. | 383.6 mio. | - |
| 2023 | - | 36.9 mio. | -7.4 mio. | 379.9 mio. | - |
| 2022 | - | 39.4 mio. | 30.4 mio. | 387.4 mio. | - |
| 2021 | - | 30.9 mio. | 23.9 mio. | 357 mio. | - |
| 2020 | - | 20.7 mio. | 15.7 mio. | 333 mio. | - |
How creditworthy is PROXEON BIOSYSTEMS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
PROXEON BIOSYSTEMS ApS has published its annual report for 2023. Gross profit came to DKK 36,919,000, and the net result was DKK -7,432,000.
About PROXEON BIOSYSTEMS ApS
PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.